Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $11.80 in the prior trading day, Elanco Animal Health Inc (NYSE: ELAN) closed at $11.55, down -2.12%. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 6.21 million shares were traded. ELAN stock price reached its highest trading level at $11.78 during the session, while it also had its lowest trading level at $11.28.
Ratios:
Our goal is to gain a better understanding of ELAN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 2.55. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on December 09, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On December 02, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $14.
Morgan Stanley Downgraded its Overweight to Equal-Weight on September 19, 2024, whereas the target price for the stock was revised from $17 to $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’24 when Harrington Michael J bought 3,500 shares for $14.85 per share. The transaction valued at 51,974 led to the insider holds 81,094 shares of the business.
Simmons Jeffrey N bought 100,000 shares of ELAN for $1,300,610 on Aug 12 ’24. The PRESIDENT, CEO AND DIRECTOR now owns 145,000 shares after completing the transaction at $13.01 per share. On May 21 ’24, another insider, DOYLE WILLIAM F, who serves as the Director of the company, bought 15,000 shares for $16.98 each. As a result, the insider paid 254,700 and bolstered with 76,330 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELAN now has a Market Capitalization of 5709776896 and an Enterprise Value of 9576774656. As of this moment, Elanco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.27, and their Forward P/E ratio for the next fiscal year is 12.71. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.28 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 2.15 whereas that against EBITDA is 10.945.
Stock Price History:
Over the past 52 weeks, ELAN has reached a high of $18.80, while it has fallen to a 52-week low of $11.40. The 50-Day Moving Average of the stock is -9.22%, while the 200-Day Moving Average is calculated to be -19.21%.
Shares Statistics:
The stock has traded on average 4.46M shares per day over the past 3-months and 3157820 shares per day over the last 10 days, according to various share statistics. A total of 494.33M shares are outstanding, with a floating share count of 486.97M. Insiders hold about 1.49% of the company’s shares, while institutions hold 98.19% stake in the company. Shares short for ELAN as of 1734048000 were 15625983 with a Short Ratio of 3.50, compared to 1731628800 on 15157396. Therefore, it implies a Short% of Shares Outstanding of 15625983 and a Short% of Float of 5.07.
